Form 4: Johnson & Johnson VP Corporate Controller Reports Stock Transactions
SEC Filing
Robert J. Decker, VP Corporate Controller at Johnson & Johnson, reports the exercise of stock options and subsequent sale of shares on February 25, 2025.
Summary
- Robert J. Decker, VP Corporate Controller of Johnson & Johnson, filed a Form 4 detailing changes in beneficial ownership.
- On February 25, 2025, Decker exercised employee stock options to acquire 6,999 shares of JNJ common stock at a price of $101.87 per share.
- Simultaneously, Decker sold 6,999 shares of JNJ common stock at a weighted average price of $165.88.
- Following these transactions, Decker directly owns 21,001 shares of JNJ common stock.
- Decker also indirectly owns 620 shares through a 401k and 134 shares through an ESOP as of January 31, 2025.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing indicates the executive's transactions in company stock.
Key Dates
| Date | Description |
|---|---|
| 02/09/2019 | Date of grant for employee stock options. |
| 01/31/2025 | Most recent reporting date for Johnson & Johnson Savings Plan (401k and ESOP). |
| 02/25/2025 | Date of stock option exercise and sale of shares. |
| 02/26/2025 | Date of Form 4 filing. |
| 02/08/2026 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.